NASDAQ:GMDA

Gamida Cell News Headlines

$6.79
-0.04 (-0.59 %)
(As of 05/10/2021 01:13 PM ET)
Add
Compare
Today's Range
$6.65
$6.84
50-Day Range
$6.78
$9.17
52-Week Range
$3.86
$15.00
Volume2,027 shs
Average Volume805,808 shs
Market Capitalization$164.45 million
P/E RatioN/A
Dividend YieldN/A
Beta2.03

Headlines

Gamida Cell (NASDAQ GMDA) News Headlines Today

SourceHeadline
Zacks: Brokerages Expect Gamida Cell Ltd. (NASDAQ:GMDA) to Announce -$0.39 Earnings Per ShareZacks: Brokerages Expect Gamida Cell Ltd. (NASDAQ:GMDA) to Announce -$0.39 Earnings Per Share
americanbankingnews.com - May 5 at 12:37 PM
Gamida Cell (GMDA) Scheduled to Post Earnings on TuesdayGamida Cell (GMDA) Scheduled to Post Earnings on Tuesday
americanbankingnews.com - May 5 at 9:31 AM
Gamida Cell Announces the Date of Its First Quarter 2021 Financial Results and WebcastGamida Cell Announces the Date of Its First Quarter 2021 Financial Results and Webcast
finance.yahoo.com - May 4 at 9:00 AM
Gamida Cell Ltd. (NASDAQ:GMDA) Given Consensus Recommendation of "Buy" by BrokeragesGamida Cell Ltd. (NASDAQ:GMDA) Given Consensus Recommendation of "Buy" by Brokerages
americanbankingnews.com - May 3 at 4:52 AM
Financial Analysis: Gamida Cell (NASDAQ:GMDA) and Aptose Biosciences (NASDAQ:APTO)Financial Analysis: Gamida Cell (NASDAQ:GMDA) and Aptose Biosciences (NASDAQ:APTO)
americanbankingnews.com - May 2 at 10:12 PM
Could The Gamida Cell Ltd. (NASDAQ:GMDA) Ownership Structure Tell Us Something Useful?Could The Gamida Cell Ltd. (NASDAQ:GMDA) Ownership Structure Tell Us Something Useful?
nasdaq.com - April 20 at 11:52 AM
-$0.39 Earnings Per Share Expected for Gamida Cell Ltd. (NASDAQ:GMDA) This Quarter-$0.39 Earnings Per Share Expected for Gamida Cell Ltd. (NASDAQ:GMDA) This Quarter
americanbankingnews.com - April 18 at 10:16 AM
Gamida Cell to Present at the 20th Annual Needham Virtual Healthcare ConferenceGamida Cell to Present at the 20th Annual Needham Virtual Healthcare Conference
finance.yahoo.com - April 7 at 12:58 PM
RBC Sees 40%-Plus Upside in These 3 StocksRBC Sees 40%-Plus Upside in These 3 Stocks
finance.yahoo.com - March 18 at 12:59 PM
Gamida Cell Presents Efficacy and Safety Results of Phase 3 Study of Omidubicel in Patients with Hematologic Malignancies at the 47th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT)Gamida Cell Presents Efficacy and Safety Results of Phase 3 Study of Omidubicel in Patients with Hematologic Malignancies at the 47th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT)
finance.yahoo.com - March 15 at 12:13 PM
Gamida Cell Ltd. (GMDA) Q4 2020 Earnings Call TranscriptGamida Cell Ltd. (GMDA) Q4 2020 Earnings Call Transcript
finance.yahoo.com - March 9 at 7:46 PM
Gamida Cell Reports Full Year 2020 Financial Results and Provides Company UpdateGamida Cell Reports Full Year 2020 Financial Results and Provides Company Update
finance.yahoo.com - March 9 at 9:46 AM
Gamida Cell to Present at Upcoming Investor ConferencesGamida Cell to Present at Upcoming Investor Conferences
finance.yahoo.com - March 3 at 7:31 AM
Gamida Cell Announces the Date of Its Full Year 2020 Financial Results and WebcastGamida Cell Announces the Date of Its Full Year 2020 Financial Results and Webcast
finance.yahoo.com - March 2 at 9:35 AM
Gamida Cell Announces Results from Phase 3 Study of Omidubicel to be Presented at the 47th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT)Gamida Cell Announces Results from Phase 3 Study of Omidubicel to be Presented at the 47th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT)
finance.yahoo.com - March 1 at 8:31 AM
2 Top Biotech Stocks to Buy in February2 Top Biotech Stocks to Buy in February
finance.yahoo.com - February 17 at 7:20 AM
Gamida Cell Announces $75 Million Financing with Highbridge Capital ManagementGamida Cell Announces $75 Million Financing with Highbridge Capital Management
finance.yahoo.com - February 16 at 8:29 AM
Is Gamida Cell Ltd. (NASDAQ:GMDA) Popular Amongst Institutions?Is Gamida Cell Ltd. (NASDAQ:GMDA) Popular Amongst Institutions?
finance.yahoo.com - February 14 at 1:40 PM
Why Is It Moving? Looking At Gamida Cells Price Action TodayWhy Is It Moving? Looking At Gamida Cell's Price Action Today
msn.com - February 10 at 3:32 PM
Gamida Cell Presents Efficacy and Safety Results of Phase 3 Study of Omidubicel in Patients with Hematologic Malignancies at the 2021 TCT Meetings of ASTCT and CIBMTRGamida Cell Presents Efficacy and Safety Results of Phase 3 Study of Omidubicel in Patients with Hematologic Malignancies at the 2021 TCT Meetings of ASTCT and CIBMTR
finance.yahoo.com - February 9 at 5:57 PM
Gamida Cell to Present Full Data from Phase 3 Study of Omidubicel at TCT, the Combined Transplantation and Cellular TherapyGamida Cell to Present Full Data from Phase 3 Study of Omidubicel at TCT, the Combined Transplantation and Cellular Therapy
bloomberg.com - January 13 at 8:53 AM
Gamida Cell to Present Full Data from Phase 3 Study of Omidubicel at TCT, the Combined Transplantation and Cellular Therapy Meetings of ASTCT and CIBMTRGamida Cell to Present Full Data from Phase 3 Study of Omidubicel at TCT, the Combined Transplantation and Cellular Therapy Meetings of ASTCT and CIBMTR
finance.yahoo.com - January 11 at 7:27 PM
Gamida Cell to Present at Upcoming January Investor ConferencesGamida Cell to Present at Upcoming January Investor Conferences
finance.yahoo.com - January 5 at 5:14 PM
Gamida Cell Announces Closing of $75 Million Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional SharesGamida Cell Announces Closing of $75 Million Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
finance.yahoo.com - December 21 at 5:36 PM
Gamida Cell Added to NASDAQ Biotechnology IndexGamida Cell Added to NASDAQ Biotechnology Index
finance.yahoo.com - December 18 at 8:32 AM
Gamida Cell Announces Pricing of $65 Million Public Offering of Ordinary SharesGamida Cell Announces Pricing of $65 Million Public Offering of Ordinary Shares
finance.yahoo.com - December 17 at 12:24 PM
Gamida Cell Announces Launch of Public Offering of Ordinary SharesGamida Cell Announces Launch of Public Offering of Ordinary Shares
finance.yahoo.com - December 17 at 1:29 AM
Is GMDA A Good Stock To Buy Now?Is GMDA A Good Stock To Buy Now?
finance.yahoo.com - December 10 at 9:53 PM
Why Is Everyone Talking About Gamida Cell Stock?Why Is Everyone Talking About Gamida Cell Stock?
finance.yahoo.com - December 10 at 8:52 AM
Gamida Cell Provides Pipeline Update, Including Detailed Results of Pivotal Phase 3 Clinical Study of Omidubicel, and Prepares to Start BLA Submission by End of 2020Gamida Cell Provides Pipeline Update, Including Detailed Results of Pivotal Phase 3 Clinical Study of Omidubicel, and Prepares to Start BLA Submission by End of 2020
finance.yahoo.com - December 9 at 8:21 AM
7 Biotechs Moving On Hematology Conference Presentations7 Biotechs Moving On Hematology Conference Presentations
benzinga.com - December 7 at 3:24 PM
Why Gamida, Scpharmaceuticals And Hookipa Are Moving TodayWhy Gamida, Scpharmaceuticals And Hookipa Are Moving Today
benzinga.com - December 7 at 3:24 PM
Gamida Cell Presents Updated, Expanded Results from Phase 1 Study of Natural Killer Cell Therapy GDA-201 at ASH Annual Meeting and ExpositionGamida Cell Presents Updated, Expanded Results from Phase 1 Study of Natural Killer Cell Therapy GDA-201 at ASH Annual Meeting and Exposition
finance.yahoo.com - December 5 at 4:08 PM
Gamida Cell to Host Virtual Pipeline Deep DiveGamida Cell to Host Virtual Pipeline Deep Dive
finance.yahoo.com - December 2 at 6:00 PM
Gamida Cell to Present at Upcoming ConferencesGamida Cell to Present at Upcoming Conferences
businesswire.com - November 24 at 8:30 AM
Were Keeping An Eye On Gamida Cells (NASDAQ:GMDA) Cash Burn RateWe're Keeping An Eye On Gamida Cell's (NASDAQ:GMDA) Cash Burn Rate
finance.yahoo.com - November 16 at 1:06 PM
Gamida Cell Reports Third Quarter 2020 Financial Results and Provides Company UpdateGamida Cell Reports Third Quarter 2020 Financial Results and Provides Company Update
finance.yahoo.com - November 10 at 8:51 AM
Gamida Cell Highlights Data Will Be Presented At American Society Of HematologyGamida Cell Highlights Data Will Be Presented At American Society Of Hematology
benzinga.com - November 5 at 11:07 PM
Gamida Cell Announces Data to Be Presented at 62nd ASH Annual Virtual MeetingGamida Cell Announces Data to Be Presented at 62nd ASH Annual Virtual Meeting
finance.yahoo.com - November 4 at 2:32 PM
Gamida Cell to Present at H.C. Wainwright 6th Annual Israel ConferenceGamida Cell to Present at H.C. Wainwright 6th Annual Israel Conference
finance.yahoo.com - November 4 at 9:32 AM
Gamida Cell Announces the Date of Its Third Quarter 2020 Financial Results and WebcastGamida Cell Announces the Date of Its Third Quarter 2020 Financial Results and Webcast
finance.yahoo.com - November 2 at 9:33 AM
Greenlighting Gamida CellGreenlighting Gamida Cell
seekingalpha.com - October 29 at 1:13 PM
Gamida Cell to Present at 2020 Virtual Cell & Gene Meeting on the MesaGamida Cell to Present at 2020 Virtual Cell & Gene Meeting on the Mesa
finance.yahoo.com - October 7 at 2:02 PM
Company News for Oct 7, 2020Company News for Oct 7, 2020
finance.yahoo.com - October 7 at 2:02 PM
Gamida Cell Announces Positive Topline Data on Secondary Endpoints from Phase 3 Clinical Study of Omidubicel in Patients with Hematologic MalignanciesGamida Cell Announces Positive Topline Data on Secondary Endpoints from Phase 3 Clinical Study of Omidubicel in Patients with Hematologic Malignancies
businesswire.com - October 6 at 1:50 PM
Gamida Cell meets all secondary endpoints in late-stage Omidubicel study in blood cancerGamida Cell meets all secondary endpoints in late-stage Omidubicel study in blood cancer
seekingalpha.com - October 6 at 8:46 AM
Gamida Cell Presents Analysis of Observational Data Demonstrating the Impact of Donor Age in Hematopoietic Stem Cell Transplant Outcomes at the Virtual Cord Blood Connect MeetingGamida Cell Presents Analysis of Observational Data Demonstrating the Impact of Donor Age in Hematopoietic Stem Cell Transplant Outcomes at the Virtual Cord Blood Connect Meeting
finance.yahoo.com - September 10 at 11:47 AM
Gamida Cell to Participate in Upcoming Investor ConferencesGamida Cell to Participate in Upcoming Investor Conferences
finance.yahoo.com - September 8 at 8:25 AM
Gamida Cell Announces Two-Part Virtual Miniseries Focused on Omidubicel to Take Place in SeptemberGamida Cell Announces Two-Part Virtual Miniseries Focused on Omidubicel to Take Place in September
finance.yahoo.com - September 3 at 12:20 PM
What Type Of Shareholders Own The Most Number of Gamida Cell Ltd. (NASDAQ:GMDA) Shares?What Type Of Shareholders Own The Most Number of Gamida Cell Ltd. (NASDAQ:GMDA) Shares?
finance.yahoo.com - August 18 at 6:19 PM
This page was last updated on 5/10/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.